Dale Lange, M.D.
NPI 1528038841 · Neurology Physician · New York, NY
Enrolled with Medicare as Practitioner - Neurology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1528038841
- Entity type
- Individual
- Primary specialty
- Neurology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 150048 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
819 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, Each Additional Hour96366 | 343 | $23 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 115 | $142 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 97 | $148 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365 | 73 | $71 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 67 | $199 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Immune Globul G/Gly/Iga Avg 46brand: Gamunex-C | 60 |
| Carbidopa/Levodopabrand: Carbidopa-Levodopa | 22 |
| Immun Globg(igg)/Malt/Iga Ov50brand: Octagam | 15 |
| Prednisone | 15 |
| Immun Glob G/Gly/Gluc/Iga 0-50brand: Gammagard S-D | 14 |
| Eculizumabbrand: Soliris | 14 |
| Immun Glob G(igg)/Gly/Iga Ov50brand: Gammagard Liquid | 13 |
| Immune Globul G/Gly/Iga Avg 46brand: Gammaked | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$5,022 across 7 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-26
- Last updated
- 2023-02-17
- Certified
- 2023-02-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.